Skip to main content

Viatris news in 2026: 13 dated events

The latest Viatris event on this page is dated Oct 30, 2026. prnewswire.com reported: Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.

Public (VTRS)Pharmaceutical Manufacturing10,000+ employeesviatris.comLinkedIn

Get Viatris' live signals in Claude or ChatGPT, or by API

AskWhat changed at Viatris this week? Use Autobound signals for viatris.com.
Dated events
15
Last 90 days
8
Latest
Oct 30, 2026

Source: Autobound Signal API · 73 signals tracked for Viatris · updated

News · latest 10

Latest Viatris news

  1. Acquisition
    Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.Viatris commenced a tender offer through its subsidiary Peach Purchaser Sub Inc. to acquire Pacira BioSciences for $36.50 per share in cash.
  2. Acquisition
  3. Asset sale
    Harrow Closes Acquisition of TYRVAYA®Viatris Inc. has sold the worldwide rights (excluding Japan) for its TYRVAYA® nasal spray to Harrow for $30 million in cash, with potential for up to $70 million in additional milestone payments.
  4. Recognition
  5. New customer
  6. Launch
    Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea...Viatris announced that its drug WAKIX® (pitolisant) has received approval from Japan's Ministry of Health, Labour and Welfare for treating excessive daytime sleepiness associated with obstructive sleep apnea syndrome and for narcolepsy.
  7. Earnings
    Viatris Lifts 2026 Outlook After Strong Second QuarterViatris reported an adjusted EBITDA of $1.2 billion for the second quarter of 2026, up 8% operationally.
  8. In development
    VTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape OutlookViatris anticipates the potential launch of its fast-acting meloxicam product.
  9. Earnings
    Viatris Announces Quarterly DividendViatris Inc. declared a quarterly dividend of $0.12 per share.
  10. Launch
    Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive PatchViatris received U.S. FDA approval for Gwyn Lo, a new once-weekly combined hormonal contraceptive patch with low-dose estrogen.

Showing 10 of 15 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Viatris with the Signal API

One POST /v1/companies/enrich call with viatris.com returns Viatris news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"viatris.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about Viatris news

What is the latest news on Viatris?
The newest event on this page is dated Oct 30, 2026. prnewswire.com reported: Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.. This page lists 15 dated events for Viatris, each with a source link.
What is going on with Viatris?
The 10 latest events on this page cover acquisition (2), asset sale (1), recognition (1), new customer (1), launch (2), earnings (2) and in development (1). The newest: Oct 30, 2026: Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc. (prnewswire.com).

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →